Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Androgens and estrogens are crucial for insulin secretion in males.

Male cells need DHT to respond to testosterone, while female cells do not.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Androgen, especially DHT, is crucial for erectile function in rats by affecting specific brain neurons.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

More body hair in young Australian women is linked to higher androstenedione levels.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Androgens don't directly affect hair cell growth or protein production.

Anabolic steroids and inflammation can disrupt androgen metabolism, potentially causing health issues.

Sebocytes play a key role in controlling androgen levels in human skin.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

The study created a new method to test drugs that affect hormone processing in skin.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

SARMs work differently in tissues due to unique interactions and structures.